These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 266179)

  • 21. Oxytocin and its analogs, methyl-substituted in ortho-, meta- or para-position of aromatic ring of phenylalanine in position 2: NMR study and biological activities.
    Budesínsky M; Procházka Z; Slaninová J
    Protein Pept Lett; 2005 May; 12(4):343-7. PubMed ID: 15907179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational properties of oxytocin in dimethyl sulfoxide solution: NMR and restrained molecular dynamics studies.
    Bhaskaran R; Chuang LC; Yu C
    Biopolymers; 1992 Dec; 32(12):1599-608. PubMed ID: 1472646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of oxytocin with Ca2+: II. Proton magnetic resonance and molecular modeling studies of conformations of the hormone and its Ca2+ complex.
    Ananthanarayanan VS; Belciug MP; Zhorov BS
    Biopolymers; 1996; 40(5):445-64. PubMed ID: 9062068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of 1-L-penicillamine-oxytocin and 1-deaminopenicillamine-oxytocin to inhibit the uterine effect of oxytocin in rabbits in vivo.
    Fuchs AR; Lopes AC
    Endocrinology; 1970 Jan; 86(1):71-6. PubMed ID: 5409455
    [No Abstract]   [Full Text] [Related]  

  • 25. Method for correlation of proton magnetic resonance assignments in different solvents: conformational transition of oxytocin and lysine vasopressin from dimethylsulfoxide to water.
    Glickson JD; Urry DW; Walter R
    Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2566-9. PubMed ID: 4506776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some pharmacologic studies on 1-L-penicillamine-oxytocin and 1-deaminopenicillamine-oxytocin: two potent oxytocin inhibitors.
    Chan WY; Fear R; Du Vigneaud V
    Endocrinology; 1967 Dec; 81(6):1267-77. PubMed ID: 6064990
    [No Abstract]   [Full Text] [Related]  

  • 27. Conformation of lysine vasopressin: a comparison with oxytocin.
    Walter R; Glickson JD; Schwartz IL; Havran RT; Meienhofer J; Urry DW
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1920-4. PubMed ID: 4505670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational and dynamic considerations in the design of peptide hormone analogs.
    Hruby VJ; Mosberg HI; Sawyer TK; Knittel JJ; Rockway TW; Ormberg J; Darman P; Chan WY; Hadley ME
    Biopolymers; 1983 Jan; 22(1):517-30. PubMed ID: 6673771
    [No Abstract]   [Full Text] [Related]  

  • 29. Secondary structure of the cyclic moiety of the peptide hormone oxytocin and its deamino analog.
    Urry DW; Ohnishi M; Walter R
    Proc Natl Acad Sci U S A; 1970 May; 66(1):111-6. PubMed ID: 5273889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational studies of oxytocin, lysine vasopressin, arginine vasopressin, and arginine vasotocin by carbon-13 nuclear magnetic resonance spectroscopy.
    Walter R; Prasad KU; Deslauriers R; Smith IC
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2086-90. PubMed ID: 4516207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of oxytocic responses to oxytocin in pregnant rats by (1-L-penicillamine)oxytocin and (1-beta-mercapto-beta, beta-diethylpropionic acid)oxytocin.
    Chan WY; Nestor JJ; Ferger MF; Du Vigneaud V
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):364-6. PubMed ID: 4834445
    [No Abstract]   [Full Text] [Related]  

  • 32. Conformational and dynamic considerations in peptide structure-function studies.
    Hruby VJ; Mosberg HI
    Peptides; 1982; 3(3):329-36. PubMed ID: 7122270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In position 7 L- and D-Tic-substituted oxytocin and deamino oxytocin: NMR study and conformational insights.
    Spyranti Z; Fragiadaki M; Magafa V; Borovickova L; Spyroulias GA; Cordopatis P; Slaninova J
    Amino Acids; 2010 Jul; 39(2):539-48. PubMed ID: 20108008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational and topographical considerations in the design of biologically active peptides.
    Hruby VJ
    Biopolymers; 1993 Jul; 33(7):1073-82. PubMed ID: 8102072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational studies on tocinamide and deaminotocinamide by 220 MHz nuclear magnetic resonance spectroscopy.
    Brewster AI; Glasel JA; Hruby VJ
    Proc Natl Acad Sci U S A; 1972 Jun; 69(6):1470-4. PubMed ID: 4504362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 8-L-tryptophan-oxytocin and determination of one of its conformational parameters.
    Bodanszky M; Tolle JC; Bednarek MA; Schiller PW
    Int J Pept Protein Res; 1981 Apr; 17(4):444-53. PubMed ID: 7309348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational effects associated with the interaction of polypeptide ligands with neurophysins.
    Chaiken IM; Randolph RE; Taylor HC
    Ann N Y Acad Sci; 1975 Feb; 248():442-50. PubMed ID: 1054558
    [No Abstract]   [Full Text] [Related]  

  • 38. Proton magnetic resonance comparison of neurohypophyseal hormones and analogs: deletion of amino groups and the conformation of lysine vasopressin.
    Glickson JD; Urry DW; Havran RT; Walter R
    Proc Natl Acad Sci U S A; 1972 Aug; 69(8):2136-40. PubMed ID: 4506084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational energy studies of oxytocin and its cyclic moiety.
    Kotelchuck D; Scheraga HA; Walter R
    Proc Natl Acad Sci U S A; 1972 Dec; 69(12):3629-33. PubMed ID: 4509324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of the peptide backbone to the action of oxytocin analogs.
    Hechter O; Kato T; Nakagawa SH; Yang F; Flouret G
    Proc Natl Acad Sci U S A; 1975 Feb; 72(2):563-6. PubMed ID: 164658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.